ストックスクリーナーアプリを入手
210.78
0.25%
-0.34
前日終値:
$211.12
開ける：
$211.42
24時間の取引高:
1.50M
Relative Volume:
0.22
時価総額：
$372.57B
収益：
$61.16B
当期純損益:
$4.19B
株価収益率:
89.26
EPS:
2.3614
ネットキャッシュフロー:
$17.82B
1週間 パフォーマンス:
+2.70%
1か月 パフォーマンス:
-9.26%
6か月 パフォーマンス:
-4.54%
1年 パフォーマンス:
+3.89%
1日の値動き範囲:
$210.15
$213.49
1週間の範囲:
$201.80
$213.49
52週間の値動き範囲:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Compare ABBV vs LLY, JNJ, MRK, AZN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
210.64 | 373.42B | 61.16B | 4.19B | 17.82B | 2.3614 |
LLY
Lilly Eli Co
|
887.88 | 801.34B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
242.01 | 576.24B | 94.19B | 26.80B | 19.70B | 11.05 |
MRK
Merck Co Inc
|
120.48 | 294.04B | 64.93B | 18.26B | 12.36B | 7.2751 |
AZN
Astrazeneca Plc
|
190.06 | 284.42B | 58.80B | 10.24B | 8.98B | 3.2788 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-02-20 | 開始されました | Barclays | Overweight |
| 2026-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 再開されました | UBS | Neutral |
| 2025-12-10 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-11-04 | ダウングレード | DZ Bank | Buy → Hold |
| 2025-10-14 | ダウングレード | Erste Group | Buy → Hold |
| 2025-10-01 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-09-17 | アップグレード | Berenberg | Hold → Buy |
| 2025-08-12 | 再開されました | Piper Sandler | Overweight |
| 2025-08-07 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-05 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-04 | アップグレード | Argus | Hold → Buy |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-05-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-01-29 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-12-11 | アップグレード | Goldman | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-10-30 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 再開されました | UBS | Neutral |
| 2023-09-29 | 開始されました | Raymond James | Outperform |
| 2023-07-25 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-04-05 | ダウングレード | Argus | Buy → Hold |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2023-02-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | アップグレード | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-11-08 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-08-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Underperform |
| 2022-05-06 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2022-02-28 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-03 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-03 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-03 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-03 | 繰り返されました | Goldman | Neutral |
| 2022-01-13 | 開始されました | Redburn | Buy |
| 2022-01-12 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-12-09 | 再開されました | Wells Fargo | Overweight |
| 2021-11-23 | アップグレード | Societe Generale | Hold → Buy |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-06-23 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | アップグレード | Argus | Hold → Buy |
| 2020-05-18 | 再開されました | BofA/Merrill | Neutral |
| 2020-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 再開されました | Morgan Stanley | Overweight |
| 2020-04-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | ダウングレード | Societe Generale | Buy → Hold |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-02-06 | 開始されました | Mizuho | Buy |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 繰り返されました | Cowen | Outperform |
| 2019-09-26 | アップグレード | Citigroup | Neutral → Buy |
| 2019-08-20 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-04-29 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
すべてを表示
Abbvie Inc (ABBV) 最新ニュース
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends - The Globe and Mail
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
AbbVie stock price forecast: sustained weak momentum as ABBV recovers modestly to $207.15 - Traders Union
AbbVie, Novartis Sue Wash. Over New 340B Drug-Pricing Law - Law360
How AbbVie’s official partnership with MLB will unfold over the course of the season - Medical Marketing and Media
AbbVie (NYSE:ABBV) Expands Awareness And Psychedelic Research Russell 1000 - Kalkine Media
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
Market Outlook: Can AbbVie Inc stock double in the next yearTrend Reversal & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Investors heavily search AbbVie Inc. (ABBV): Here is what you need to know - MSN
AbbVie Inc stock faces renewed scrutiny as Mercy Investment files shareholder proposal amid pipeline - AD HOC NEWS
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - Yahoo Finance
LLY or ABBV: Which Drugmaker is Likely to Offer Better Upside in 2026? - TradingView
AbbVie stock price forecast for 2040: Immunology pipeline and oncology expansion support long-term path toward $550 - Traders Union
Pensionfund Sabic Invests $4.02 Million in AbbVie Inc. $ABBV - MarketBeat
Meadowbrook Wealth Management LLC Grows Stake in AbbVie Inc. $ABBV - MarketBeat
DAVENPORT & Co LLC Sells 5,545 Shares of AbbVie Inc. $ABBV - MarketBeat
62,112 Shares in AbbVie Inc. $ABBV Bought by E. Ohman J or Asset Management AB - MarketBeat
Is AbbVie (ABBV) one of the Best Psychedelic Stocks to Buy in 2026? - Insider Monkey
AbbVie Inc stock faces activist pressure as Mercy Investment files shareholder proposal amid pipelin - AD HOC NEWS
AbbVie’s sports marketing move - eMarketer
AbbVie Inc. stock faces activist pressure as Mercy Investment files shareholder proposal amid pipeli - AD HOC NEWS
AbbVie Named Official Pharmaceutical Partner of Major League Baseball - Investing News Network
AbbVie Stock Outlook 2026: Performance, Valuation, and Dividend YieldNews and Statistics - IndexBox
AbbVie partners with MLB to boost cancer nonprofit donations through expanded campaign - Traders Union
Protagonist Partners With Johnson & Johnson To Compete With AbbVie's Skyrizi - Seeking Alpha
AbbVie (ABBV) Teams Up with MLB in Nationwide Cancer Initiative - GuruFocus
AbbVie and Bristol Myers Squibb's Dividend Performance - Intellectia AI
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill. - The Motley Fool
Overbrook Management Corp Acquires New Holdings in AbbVie Inc. $ABBV - MarketBeat
SG Americas Securities LLC Sells 831,382 Shares of AbbVie Inc. $ABBV - MarketBeat
Breast Implants Market Is Booming So Rapidly | Abbvie, Inc., Ideal Implant Incத் - openPR.com
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC - MarketBeat
AbbVie Inc. $ABBV is BDF Gestion's 10th Largest Position - MarketBeat
Assenagon Asset Management S.A. Sells 267,547 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Slides -7.5% With A 5-Day Losing Spree - Trefis
5-Day Sell-Off Sends AbbVie Stock Down 7.5% - Trefis
Mercy Investment Submits a Shareholder Proposal to AbbVie - marketscreener.com
AbbVie : 2025 Annual Report on Form 10-K and 2026 Proxy Statement - marketscreener.com
Strong decade for AbbVie (NYSE: ABBV) as 2026 proxy outlines returns, pay and governance - Stock Titan
AbbVie Escapes Ill. Genetic Privacy Lawsuit - Law360
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now - The Motley Fool
AbbVie Inc. $ABBV Shares Purchased by Wealth Enhancement Advisory Services LLC - MarketBeat
AbbVie Inc. $ABBV Stake Reduced by Gradient Investments LLC - MarketBeat
Nordea Investment Management AB Has $950.63 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie, Inc. Trade Ideas — LSX:A1J84E - TradingView
AbbVie Inc. $ABBV Shares Acquired by Procyon Advisors LLC - MarketBeat
MassMutual Private Wealth & Trust FSB Has $39.20 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Hamlin Capital Management LLC Has $213.68 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Aventura Private Wealth LLC Buys $2.14 Million Stake in AbbVie Inc. - National Today
CWA Asset Management Group LLC Purchases 11,964 Shares of AbbVie Inc. $ABBV - MarketBeat
Aventura Private Wealth LLC Takes $2.14 Million Position in AbbVie Inc. $ABBV - MarketBeat
Abbvie Inc (ABBV) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
0.21%
大文字化:
|
ボリューム (24 時間):